Founding Investor · Cannabis & HealthTech
Sanity Group
Europe's leading cannabis health company.
- Year
- 2018
- Status
- Exit to Organigram (2026)
- Type
- Founding Investor
- Sector
- Cannabis & HealthTech
About the investment
Sanity Group is Germany's leading medical cannabis company, co-founded and led by Finn Hänsel in 2018. In 2026 Sanity Group was acquired by Canadian cannabis market leader Organigram Global at a total valuation of up to €250M (€130M upfront). Mauerkatze participated as a founding investor and realised a successful Sanity Group exit.
Mauerkatze & Sanity Group
Mauerkatze is the angel and venture capital vehicle of Finn Hänsel (known for the Sanity Group exit). We back Sanity Group as founding investor with capital, network and operational experience from the Berlin tech and VC ecosystem.